RGMP Stock: Regnum Corp. Stock Price, Analysis & Insights
Get live RGMP stock price $0.00, comprehensive Regnum Corp. stock analysis, charts, news, and expert forecast. Real-time RGMP stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functioning as a C-C chemokine receptor type 5 (CCR5) an...
Company Information
- CEO
- Robert J. Stubblefield
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1
Contact Information
- Website
- https://www.regnumcorp.com
- Address
- 600 Third Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -0.82) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Regnum Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Regnum Corp.
- ⚠Investors should consider how Regnum Corp. fits within their overall portfolio allocation
Market Cap
2.29K
Beta
-0.82
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RGMP with peer companies:
- Price
- $0.18
- Market cap
- 207.88K
- Price
- $0.00
- Market cap
- 7.94K
- Price
- $0.00
- Market cap
- 14.13K
- Price
- $0.00
- Market cap
- 2.79K
- Price
- $0.00
- Market cap
- 122.12K
- Price
- $0.00
- Market cap
- 124.11K
- Price
- $0.00
- Market cap
- 128.12K
- Price
- $0.00
- Market cap
- 453
- Price
- $0.00
- Market cap
- 7.08K
- Price
- $0.00
- Market cap
- 13.63K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.